Top

Notice of Intent to Sole Source - Becton, Dickinson and Company

Active

NOI-CC-25-009064Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

The National Institutes of Health Clinical Center, specifically the Center for Cellular Engineering, has issued a notice of intent to sole source the procurement of BD Rhapsody Single-Cell Analysis reagent kits and a scanner upgrade kit. This acquisition is intended to support clinical research protocols involving CAR-T cells and other cell therapies by enabling multiomic analysis of open chromatin accessibility and transcriptomes. The procurement includes the BD Rhapsody HT Xpress Package, 8-Lane Cartridge, Tagmentation and Supplemental Reagents Kit, Multiomic ATAC-Seq Amplification Kit, and a Rhapsody Scanner Upgrade Kit. BD Biosciences is identified as the only vendor capable of providing high quality reagents compatible with the existing BD Rhapsody system, scanner, and express instruments in the laboratory. The projected cost for this one-time delivery is 23,491.28 dollars, with a period of performance from August 7, 2025, to December 5, 2025. The procurement is conducted under FAR Part 13 Simplified Acquisition Procedures, allowing for a sole source award as the requirement falls below the simplified acquisition threshold. Key requirements include strict temperature maintenance during overnight shipping, a minimum shelf life of three months for sequencing reagents and six months for library generation kits, and the provision of technical support at no additional cost. The contractor is responsible for the replacement costs of any damaged, defective, or incomplete shipments delivered to the CCE PACT laboratory in Bethesda, Maryland.

General Info

NIH intends sole-source procurement of BD Rhapsody single-cell analysis reagents and equipment.

Agency

Department Of Health And Human Services → National Institutes Of Health - Cc

NAICS

339113 - Surgical Appliance and Supplies Manufacturing

Place of Performance

Bethesda, MD, 20892, USA

Set-Aside

NONE

Documents

SOW for BD Rhapsody Single-Cell Analysis Reagent Kits Procurement

sow

High

AI Contract Breakdown

Uniform Contract Format

Timeline

PostedSep 2

special-notice

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

AgencyDepartment Of Health And Human Services → National Institutes Of Health - Cc

Contacts1 person available

OfficeBETHESDA, MD, 20892, USA

Organization / AgencyDepartment Of Health And Human Services → National Institutes Of Health - Cc

Office AddressBETHESDA, MD, 20892, USA

Contacts

Chris Ryssa Nix

contact@example.gov

Full Description

This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. This procurement is for BD Rhapsody HT Xpress Package, BD Rhapsody 8-Lane Cartridge, BD Rhapsody Tagmentation and Supplemental Reagents Kit, BD Rhapsody Multiomic ATAC-Seq Amplification Kit and Rhapsody Scanner Upgrade Kit. These kits provide the necessary reagents for the preparation of single cell mRNA and ATAC-Seq libraries simultaneously with the BD Rhapsody Single-Cell Analysis system to generate multiomic analysis of open chromatin accessibility and transcriptome of single cells in one experiment. BD Biosciences is the only vendor that provides high quality reagents and compatible with its (BD) Rhapsody single-cell analysis system that we have in the lab. This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 - Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government. Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Ryssa Nix, Contract Specialist via email to contact@example.gov by close date.